Compounds / TB-500

TB-500

Thymosin Beta-4 fragment

TB-500 has 1 registered human trial on record. It is marketed for 3 different uses.

In short

  • 1 registered human trial exists for TB-500.
  • No registered trial lists soft-tissue & tendon recovery, injury healing or hair growth as a studied condition.
  • TB-500 is not FDA-approved for any use.
  • What has actually been studied: atherosclerotic cardiovascular diseases, endothelial dysfunction.
  • 1 study is open to new participants, so this may change.
  • Last checked against ClinicalTrials.gov on 2026-07-27.
1
Registered human trials
1
Recruiting or running
No
FDA approved
Pre
P1
P2
P3
Furthest stage reached

What it's sold for

  • Soft-tissue & tendon recovery
  • Injury healing
  • Hair growth

What has actually been tested

  • Atherosclerotic Cardiovascular Diseases
  • Endothelial Dysfunction

Is it studied for what it's sold for?

Each claim below is matched against the condition and title fields of every registered trial. Not listed means no trial names it as a studied condition — not that it has been disproven, and not that no trial touches it indirectly.

Not listed Soft-tissue & tendon recovery
Not listed Injury healing
Not listed Hair growth

Every trial on record

Every registered human study we can find for TB-500. Click any ID to read the original record — we would rather you checked us than trusted us.

Trial IDTitleConditionPhaseStatusEnrolled
NCT07487363 TB-500 (Thymosin Beta 4 17-23 Fragment) for Cardiovascular Biomarkers in Stable ASCVD Atherosclerotic Cardiovascular Diseases, Endothelial Dysfunction Phase 2 Recruiting now 80
Read this
A trial count is not a verdict
These numbers describe how much has been formally studied in humans, not whether something works or is safe for you. A compound can be tested for one condition and sold for another — which is usually the story. This page is automated aggregation from public registries; no physician has reviewed it. Take anything here to a clinician.

Common questions about TB-500

How many human trials does TB-500 have?

1. That is the number of registered interventional human studies we can find, each listed on this page with a link to its original record.

Is TB-500 FDA approved?

No. TB-500 is not approved by the FDA for any indication. Compounded or "research use only" preparations are not FDA-approved and receive no premarket review for safety, effectiveness, or manufacturing quality.

What is TB-500 actually being tested for?

Registered studies cover: atherosclerotic cardiovascular diseases, endothelial dysfunction. Compare that to what it is marketed for — the two lists are often different, which is the whole point of this page.

Where does this data come from?

ClinicalTrials.gov, the US public registry of clinical studies. We count interventional human studies only — observational studies are not evidence of effect. Every trial on this page links to its original record so you can check us rather than trust us.

Get told when this changes

One email a week: what moved in the research, and which claims the record doesn't support. Free, and you can leave in one click.